Additional file 2: Figure S1. of Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis

Relative risks and 95 % confidence intervals for risk of adverse clinical events associated with quintile of facility-level proportions of patients with at least two of three CKD-MBD biomarkers out of or above target ranges, using a PTH target range of 150–300 pg/mL. CKD-MBD, chronic kidney disease-mineral bone disorder; PTH, parathyroid hormone. (PDF 67 kb)